1. Sexually transmitted infections in the context of haematological malignancies
- Author
-
Alsuliman, Tamim, Musiu, Paolo, Stocker, Nicolas, Desnica, Lana, El-Cheikh, Jean, Sestili, Simona, Srour, Micha, Marjanovic, Zora, and Alrstom, Ali
- Abstract
Sexually transmitted infections (STIs) are a difficult health challenge for immunocompromised patients. Patients treated for several haematological malignancies have further compromised immune systems. Furthermore, many chemotherapies, alone or associated with haematopoietic stem-cell transplantation, make the body's natural barriers extremely fragile. STIs can negatively impact both patient morbidity and mortality. In this Series paper, we discuss Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, human immunodeficiency virus, herpes simplex virus, human papilloma virus, and hepatitis B virus, as we found them to be associated with increased risks for haematological malignancy treatments, either by incidence or by severity. Protective measures and vaccines for patients with haematological malignancies are also discussed. Large, well conducted studies should be encouraged, with the aim to systematically analyse the impacts of STIs in patients with haematological malignancies, especially given the difficulties that antimicrobial resistance can confer to patient management.
- Published
- 2024
- Full Text
- View/download PDF